UK law firm RPC has bolstered its M&A capabilities in Singapore with the addition of Quahe Woo & Palmer (QWP) director Kiat Wee Lau to its corporate practice.


He joins RPC’s Singapore-based corporate practice, which was launched in July 2023 with the addition of practice head Kenneth Leong, another hire from QWP.

Lau, who also co-led QWP’s sustainability practice, is an M&A specialist with a focus on financial regulation, funds, and Variable Capital Companies (VCC) formation. He advises private equity houses, venture capital firms, private wealth investors, and hedge funds on investments in Singapore, Indonesia, China, India and across the APAC region.

Lau’s clients have included Tencent Holdings, JTC Corporation, Nestle, City Developments Limited, Bain Capital, Petronas, Morgan Stanley Infrastructure, and Blackstone Group.

He had been a director at Quahe Woo since 2019, and a partner at WongPartnership prior to that.

“With Singapore continuing to position itself as a major financial centre for the region, with access to key markets such as India and Indonesia, Kiat Wee's appointment further strengthens our regional corporate offering and will enable us to better support our clients across Asia," said Antony Sassi, RPC’s Asia managing partner, in a statement.

RPC now has 9 partners in Singapore.





Related Articles

A&O Shearman advises Allianz on $1.6 bln Singapore insurance deal

by Nimitt Dixit |

A&O Shearman has advised German insurer Allianz on the acquisition of a 51 percent stake in Singapore's Income Insurance for S$2.2 billion ($1.6 billion), the latest major deal in Singapore’s buzzing insurance sector.

INDIA REPORT: Merger Momentum

by Nimitt Dixit |

Despite global uncertainties, India's M&A landscape remains robust, with domestic deals driving growth and diverse sectors attracting investments. Experts predict a positive outlook for H2 2024, bolstered by policy continuity and abundant dry powder.

Simpson Thacher, Nishimura act on Blackstone’s $2.17 bln Japan pharma sale

by Nimitt Dixit |

Japanese law firm Nishimura & Asahi has represented private equity group MBK Partners on its acquisition of drugmaker Alinamin Pharmaceuticals for 350 billion yen ($2.17 billion) from PE giant Blackstone, which was advised by its longstanding firm Simpson Thacher & Bartlett.